T
TransMedics Group D
D
TMDX
75.490
USD
-3.68
(-4.65%)
قبل الجلسة·79.130USD+3.640(+4.82%)
حجم التداول
26,606
الربح لكل سهم
1
العائد الربحي
-
P/E
20
حجم السوق
2,617,626,696
العنوان: TransMedics Group
القطاع: الرعاية الصحية
الصناعة: Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The companyhas developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.